Pills, Power, and Policy, The Struggle for Drug Reform in Cold War America and Its Consequences (Heftet (myke permer))

Dominique A. Tobbell is Assistant Professor in the Program in the History of Medicine and the Graduate Program in the History of Science, Technology, and Medicine at the University of Minnesota, Twin Cities. She is also the oral historian for the University of Minnesota's Academic Health Center History Project.

Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.

Foreword Acknowledgments Introduction: Pharmaceutical Politics, Then and Now Part I: Forging Pharmaceutical Relations 1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network 2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship 3. Professional Relations: Crafting the Public Image of the Health Care Team Part II: Allied against Reform 4. Cold War Alliances: Kefauver's Bid for Pharmaceutical Reform 5. Expert Alliances: The Creation of the Drug Research Board 6. Generic Alliances and the Backlash against Regulatory Reform Epilogue Notes Bibliography Index